Behavioural characterization and amounts of brain monoamines and their metabolites in mice lacking histamine h1 receptors

Neuroscience

Volumn 87, Issue 2, 1998, Pages 479-487

  Yanai, K ^a   Son, L Z ^a   Endou, M ^a   Sakurai, E ^a   Nakagawasai, O ^b   Tadano, T ^b   Kisara, K ^b   Inoue, I ^c   Watanabe, T ^a,c  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

5 hydroxytryptamine; Behaviour; Circadian rhythm; Gene targeting; Histamine H1 receptors; Isolation induced aggression

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; DOPAMINE; HISTAMINE H1 RECEPTOR; HOMOVANILLIC ACID; SEROTONIN;

AGGRESSION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BRAIN METABOLISM; CIRCADIAN RHYTHM; COGNITION; GENE TARGETING; MAZE TEST; MONOAMINE METABOLISM; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL;

AGGRESSION; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BIOGENIC MONOAMINES; BRAIN CHEMISTRY; DEPRESSION; FORMALDEHYDE; MALE; MICE; MOTOR ACTIVITY; MUSCULOSKELETAL EQUILIBRIUM; MUTATION; PAIN MEASUREMENT; RECEPTORS, HISTAMINE H1;

EID: 0032551641     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00167-5     Document Type: Article

References (45)

1. Arrang J. M., Garberg M., Lancelot J. C., Lacomate J. M., Pollard H., Robba M., Schnuck W., Schwartz J. M. Highly potent and selective ligands for histamine H3-receptors. Nature. 327:1987;117-123.
2. Barnett A., Malick J. B., Taber R. I. Effects of antihistamines on isolation-induced fighting in mice. Psychopharmacology. 19:1971;359-365.
3. 125I]iodobolpyramine. Neuroscience. 26:1988;553-600.
4. Cacabelos R., Alvarez X. A. Histidine decarboxylase inhibition induced by α-fluoromethylhistidine provokes learning-related hypokinetic activity. Agents Actions. 33:1991;131-134.
5. Cases L., Seif I., Grimsby J., Gaspar P., Chen K., Pournin S., Müller U., Aguest M., Babinet C., Shih J. C., Maeyer E. D. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science. 268:1995;1763-1766.
6. 3H]-acetylcholine from slices of rat entorhinal cortex: evidence for the possible existence of H3 receptor subtypes. Br. J. Pharmac. 107:1992;919-923.
7. De Almedia M. A. M., Izquierdo I. Memory facilitation by histamine. Archs int. Pharmacodyn. Thér. 283:1986;193-198.
8. Doi T., Sakata T., Yoshimatsu H., Machidori H., Kurokawa M., Jayasekara L. A., Niki N. Hypothalamic neuronal histamine regulates feeding circadian rhythm in rats. Brain Res. 641:1994;311-318.
9. Gerlai R. Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype? Trends Neurosci. 19:1996;177-181.
10. Hill S. J. Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmac. Rev. 42:1990;45-83.
11. Hough L. B. Cellular localization and possible functions for brain histamine: recent progress. Prog. Neurobiol. 30:1988;469-505.
12. Huston J. P., Wagner U., Hasenöhrl R. U. The tuberomammillary nucleus projections in the control of learning, memory and reinforcement processes: evidence for an inhibitory role. Behav. Brain Res. 83:1997;97-105.
13. Inoue I., Taniuchi I., Kitamura D., Jenkins N. A., Gilbert D. J., Copeland N. G., Watanabe T. Characteristics of the mouse genomic histamine H1 receptor gene. Genomics. 36:1996;178-181.
14. Inoue I., Yanai K., Kitamura D., Taniuchi I., Kobayashi T., Watanabe T., Watanabe T. Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors. Proc. natn. Acad. Sci. U.S.A. 93:1996;13316-13320.
15. Itoh J., Nabeshima T., Kameyama Utility of an elevated plus-maze for the elevation of memory in mice: effects of nootropics, scoplamine and electroconvulsive shock. Psychopharmacology. 101:1990;27-33.
16. Kalivas P. W. Histamine induced arousal in the conscious and pentobarbital-pretreated rat. J. Pharmac. exp. Ther. 222:1982;37-42.
17. Kamei C., Chung Y. H., Tasaka K. Influence of central H1-blockers on the step-through active avoidance response in rats. Psychopharmacology. 102:1990;312-318.
18. Kamei C., Tasaka K. Participation of histamine in the step-through active avoidance and its inhibition by H1-blockers. Jap. J. Pharmac. 57:1991;473-482.
19. Leurs R., Smit M. J., Timmerman H. Molecular pharmacological aspects of histamine receptors. Pharmac. Ther. 66:1995;413-463.
20. Mayford M., Abel T., Kandel E. R. Transgenic approach to cognition. Curr. Opin. Neurobiol. 5:1995;141-148.
21. Meguro K., Yanai K., Sakai N., Sakurai E., Maeyama K., Sasaki H., Watanabe T. Effects of thioperamide, a histamine H3 antagonist, on the step-through passive avoidance response and histidine decarboxylase activity in senescence accelerated mice (SAM). Biochem. Behav. 50:1995;321-325.
22. Miyazaki S., Imaizumi M., Onodera K. Ameliorating effects of histidine on scoplamine-induced learning deficits using an elevated plus-maze test in mice. Life Sci. 56:1995;1563-1570.
23. Nicholson A. N. New antihistamines free of sedative side effects. Trends pharmac. Sci. 8:1987;247-249.
24. Noguchi S., Fukuda Y., Inukai T. Possible contributory role of the central histaminergic system in the forced swimming model. Arzneimittel-Forsch. Drog Res. 42:1992;611-613.
25. Noguchi S., Inukai T., Kuno T., Tanaka C. The suppression of olfactory bulbectomy-induced muricide by antidepressants and antihistamines via histamine H1 receptor blocking. Physiol. Behav. 51:1992;1123-1127.
26. Onodera K., Ogura Y. Effects of histaminergic drugs on muricide induced by thiamin deficiency. Jap. J. Pharmac. 34:1984;15-21.
27. Onodera K., Yamatodani A., Watanabe T., Wada H. Neuropharmacology of the histaminergic neuron system in the brain and its relationship with behavioral disorders. Prog. Neurobiol. 42:1994;685-702.
28. Panula P., Yang H. Y. T., Costa E. Histamine-containing neurons in the rat hypothalamus. Proc. natn. Acad. Sci. U.S.A. 81:1984;2572-2576.
29. Ray A., Sharma K. K., Sen P. Effects of histaminergic drugs on footshock-induced aggressive behavior in rats. Eur. J. Pharmac. 73:1981;217-219.
30. Richelson E. (1992) Histamine receptors in the central nervous system. In The Histamine Receptor (eds Schwartz J. C. and Haas H. L.), pp. 271-295. Wiley-Liss, New York.
31. 125I]iodinated probes. Proc. natn. Acad. Sci. U.S.A. 87:1990;1658-1662.
32. Rumore M. M., Pharm D., Schlichting D. A. Analgesic effects of antihistaminics. Life Sci. 36:1985;43-416.
33. v mice. Life Sci. 48:1991;2397-2404.
34. Sakai N., Onodera K., Maeyama K., Yanai K., Watanabe T. Effects of α-fluoromethylhistidine and metoprine on locomotor activity and brain histamine contents in mice. Life Sci. 51:1992;397-405.
35. Sakai N., Sakurai E., Onodera K., Sakurai E., Asada H., Miura Y., Watanabe T. Long-term depletion of brain histamine induced by α-fluoromethylhistidine increases feeding-associated locomotor activity in mice with a modulation of brain amino acid levels. Behav. Brain Res. 72:1996;83-88.
36. Sakurada T., Katsumata K., Tan-No S., Sakurada S., Kisara K. The capsaicin test in mice for evaluating tachykinin antagonists in the spinal cord. Neuropharmacology. 31:1992;1279-1285.
37. Saudou F., Amara D. A., Dierich A., Lemeur M., Ramboz S., Segu L., Buhot M.-C., Hen R. Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science. 265:1994;1875-1878.
38. Schwartz J. C., Arrang J. M., Garbarg M., Pollard H., Ruat M. Histaminergic transmission in the mammalian brain. Physiol. Rev. 71:1991;1-51.
39. Schlicker E., Betz R., Göethert Histamine H3 receptor-mediated inhibition of serotonin release in the rat brain cortex. Naunyn-Schmiedebergs's Arch. Pharmac. 337:1988;588-590.
40. Tuomisto L., Eriksson L. Cardiovascular and behavioral changes after i.c.v. infusions of histamine and agonists in conscious goats. Agents Actions. 10:1980;165-166.
41. Wada H., Inagaki N., Yamatodani A., Watanabe T. Is the histaminergic neuron system a regulatory center for whole brain activity? Trends Neurosci. 14:1991;415-418.
42. Watanabe T., Yamatodani A., Maeyama K., Wada H. Pharmacology of α-fluoromethylhistidine, a specific inhibitor of histidine decarboxylase. Trends pharmac. Sci. 11:1990;363-367.
43. Watanabe T., Taguchi Y., Shiosaka S., Tanaka J., Kubota H., Terano Y., Tohyama M., Wada H. Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res. 295:1984;13-25.
44. Wei L.-N. Transgenic animals as new approaches in pharmacological studies. A. Rev. Pharmac. Toxicol. 37:1997;119-141.
45. Yanai K., Ryu J. H., Watanabe T., Iwata R., Ido T., Sawai Y., Ito T., Itoh M. Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography. Br. J. Pharmac. 116:1995;1649-1655.